Depressive disorders in patients with epilepsy: Why should neurologists care?

Taoufik Alsaadi, Khalid Zamel, Ahmed Sameer, Waseem Fathalla, Iyad Koudier

Emirates League Against Epilepsy (ELAE), Sheikh Khalifa Medical City, Abu Dhabi, UAE;.

DOI: 10.4236/health.2013.56A1003                

Abstract

Epilepsy is a complex disorder that is commonly associated with brain dysfunction, social isolation, and vocational difficulty. Each of these factors may contribute to the increased prevalence of psychiatric illness in epilepsy, but emerging evidence is providing a more complete and clearer elucidation of the problem. Clinical investigations have consistently demonstrated that depression has a large impact on subjective health status. In patients with recurrent seizures, depression appears to have a stronger association with quality of life than does the seizure rate. In fact, depression is second only to medication toxicity as the clinical factor that explains the greatest variance in quality of life. Only a small number of studies have investigated the plausible neurobiological mechanisms of depression in epilepsy, but preliminary data suggest that underlying brain dysfunction may be a more important predictor than vocational or social disability. Furthermore, specific aspects of hippocampal dysfunction may be a causal factor in the genesis and maintenance of depression in temporal lobe epilepsy. Current treatment recommendations for depression in epilepsy are similar to those for otherwise neurologically normal depressed patients, emphasizing the role of serotonin reuptake inhibitors, but certain antidepressants should be used with caution. Ongoing studies are attempting to define optimal treatment strategies, and more definitive data to guide clinical management are expected to become available in the near future.

 

Keywords

Depression; Seizures; Temporal Lobe Epilepsy; Quality of Life; Serotonin Reuptake Inhibitors (SSRIs)

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Tellez-Zenteno, J.F., Matijevic, S. and Wiebe, S. (2005) Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia, 46, 1955-1962. doi:10.1111/j.1528-1167.2005.00344.x
[2]	Ettinger, A., Reed, M. and Cramer, J. (2004) Depression and comorbidity in community based patients with epilepsy or asthma. Neurology, 63, 1008-1014. doi:10.1212/01.WNL.0000138430.11829.61
[3]	Gaitatzis, A., Carroll, K., Majeed, A. and Sander, J.W. (2004) The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia, 45, 1613-1622. doi:10.1111/j.0013-9580.2004.17504.x
[4]	Ettinger, A.B., Reed, M.L., Goldberg, J.F. and Hirschfeld, R.M. (2005) Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology, 65, 535- 540. doi:10.1212/01.wnl.0000172917.70752.05
[5]	Tellez-Zenteno, J.F., Patten, S.B., Jetté, N., et al. (2007) Psychiatric comorbidity in epilepsy: A population-based analysis. Epilepsia, 48, 2336-2344.
[6]	Jones, J.E., Hermann, B.P., Barry, J.J., Gilliam, F.G., Kanner, A.M. and Meador, K.J. (2003) Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy & Behavior, 4, S31-S38. doi:10.1016/j.yebeh.2003.08.019
[7]	Pompili, M., Girardi, P. and Tatarelli, R. (2006) Death from suicide versus mortality from epilepsy in the epilepsies: a meta-analysis. Epilepsy & Behavior, 9, 641-648. doi:10.1016/j.yebeh.2006.06.019
[8]	Christensen, J., Vestergaard, M., Mortensen, P.B., Sidenius, P. and Agerbo, E. (2007) Epilepsy and risk of suicide: A population-based case-control study. The Lancet Neurology, 6, 693-698. doi:10.1016/S1474-4422(07)70175-8
[9]	Mazza, M., Bria, P. and Mazza, S. (2007) Depression and suicide in epilepsy: Fact or artifact? Journal of the Neurological Sciences, 260, 300-301. doi:10.1016/j.jns.2007.04.007
[10]	Robertson, M.M., Trimble, M.R. and Townsend, H.R. (1987) Phenomenology of depression in epilepsy. Epilepsia, 28, 364-372. doi:10.1111/j.1528-1157.1987.tb03659.x
[11]	Mendez, M.F., Cummings, J.L. and Benson, D.F. (1986) Depression in epilepsy. Significance and phenomenology. Archives of Neurology, 43, 766-770. doi:10.1001/archneur.1986.00520080014012
[12]	Jacoby, A., Baker, G.A., Steen, N., Potts, P. and Chadwick, D.W. (1996) The clinical course of epilepsy and its psychosocial correlates: Findings from a UK community study. Epilepsia, 37, 148-161. doi:10.1111/j.1528-1157.1996.tb00006.x
[13]	O’Donoghue, M.F., Goodridge, D.M., Redhead, K., Sander, J.W. and Duncan, J.S. (1999) Assessing the psychosocial consequences of epilepsy: A community-based study. British Journal of General Practice, 49, 211-214.
[14]	Seminario, N.A., Farias, S.T., Jorgensen, J., Bourgeois, J.A. and Seyal, M. (2009) Epilepsy & Behavior, 15, 362- 366. doi:10.1016/j.yebeh.2009.05.007
[15]	Beghi, E., Spagnoli, P., Airoldi, L., et al. (2002) Emotional and affective disturbances in patients with epilepsy. Epilepsy & Behavior, 3, 255-261. doi:10.1016/S1525-5050(02)00008-2
[16]	Lehrner, J., Kalchmayr, R., Serles, W., Olbrich, A., Pataraia, E., Aull, S., Bache, J., et al. (1999) Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure, 8, 88-92. doi:10.1053/seiz.1999.0272
[17]	Perrine, K., Hermann, B.P., Meador, K.J., et al. (1995) The relationship of neuropsychological functioning to quality of life in epilepsy. Archives of Neurology, 52, 997- 1003. doi:10.1001/archneur.1995.00540340089017
[18]	Gilliam, F., Kuzniecky, R., Faught, E., Black, L., Carpenter, G. and Schrodt, R. (1997) Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia, 38, 233-236. doi:10.1111/j.1528-1157.1997.tb01102.x
[19]	Boylan, L.S., Flint, L.A., Labovitz, D.L., Jackson, S.C., Starner, K. and Devinsky, O. (2004) Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology, 62, 258-261. doi:10.1212/01.WNL.0000103282.62353.85
[20]	Cramer, J.A., Blum, M., Reed, M. and Fanning, K. (2003) Epilepsy impact project. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy & Behavior, 4, 515-521. doi:10.1016/j.yebeh.2003.07.009
[21]	Harris, E.C. and Barraclough, B. (1997) Suicide as an outcome for mental disorders: A meta-analysis. The British Journal of Psychiatry, 170, 205-228. doi:10.1192/bjp.170.3.205
[22]	Cramer, J.A., Blum, D., Fanning, K., Reed, M. and Epilepsy Impact Project Group (2004) The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy & Behavior, 5, 337-342. doi:10.1016/j.yebeh.2004.01.010
[23]	Hitiris, N., Mohanraj, R., Norrie, J., et al. (2007) Predictors of pharmacoresistant epilepsy. Epilepsy Research, 75, 192-196. doi:10.1016/j.eplepsyres.2007.06.003
[24]	Kanner, A.M., Byrne, R., Chicharro, A., Wuu, J. and Frey, M. (2009) A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology, 72, 793-799. doi:10.1212/01.wnl.0000343850.85763.9c
[25]	Kanner, A.M. and Palac, S. (2000) Depression in epilepsy: A common but often unrecognized comorbid malady. Epilepsy & Behavior, 1, 37-51. doi:10.1006/ebeh.2000.0030
[26]	Mazarati, A., Shin, D., Auvin, S., et al. (2007) Kindling epileptogenesis in immature rats leads to persistent depressive behavior. Epilepsy & Behavior, 10, 377-383. doi:10.1016/j.yebeh.2007.02.001
[27]	Kanner, A.M. (2005) Depression in epilepsy: A neurobiologic perspective. Epilepsy Currents, 5, 21-27. doi:10.1111/j.1535-7597.2005.05106.x
[28]	Drevets, W.C., Frank, E., Price, J.C., et al. (1999) PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry, 46, 1375-1387. doi:10.1016/S0006-3223(99)00189-4
[29]	Jobe, P.C., Dailey, J.W. and Wernicke, J.F. (1999) A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Critical Reviews in Neurobiology, 13, 317-356.
[30]	Lothe, A., Didelot, A., Hammers, A., et al. (2008) Comorbidity between temporal lobe epilepsy and depression: A [18F] MPPF PET study. Brain, 131, 2765-2782. doi:10.1093/brain/awn194
[31]	Theodore, W.H., Giovacchini, G., Bonwetsch, R., et al. (2006) The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography. Epilepsia, 47, 499-503. doi:10.1111/j.1528-1167.2006.00458.x
[32]	Forsgren, L. and Nystrom, L. (1999) An incident case referent study of epileptic seizures in adults. Epilepsy Research, 6, 66-81. doi:10.1016/0920-1211(90)90010-S
[33]	Hesdorffer, D.C., Hauser, W.A., Annegers, J.F. and Cascino, G. (2000) Major depression is a risk factor for seizures in older adults. Annals of Neurology, 47, 246-249. doi:10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.0.CO;2-E
[34]	Hesdorffer, D.C., Hauser, W.A., Olafsson, E., Ludvigsson, P. and Kjartansson, O. (2006) Depression and suicidal attempt as risk factor for incidental unprovoked seizures. Annals of Neurology, 59, 35-41. doi:10.1002/ana.20685
[35]	Lewis, A. (1934) Melancholia: A historical review. The Journal of Mental Science, 80, 1-42.
[36]	Sheline, Y.I. (2003) Neuroimaging studies of mood disorder effects on the brain. Biological Psychiatry, 54, 338- 352. doi:10.1016/S0006-3223(03)00347-0
[37]	Sheline, Y.I., Gado, M.H. and Kraemer, H.C. (2003) Untreated depression and hippocampal volume loss. The American Journal of Psychiatry, 160, 1516-1518. doi:10.1176/appi.ajp.160.8.1516
[38]	Quiske, A., Helmstaedter, C., Lux, S. and Elger, C.E. (2000) Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Research, 39, 121-125. doi:10.1016/S0920-1211(99)00117-5
[39]	Gilliam, F.G., Maton, B.M., Martin, R.C., et al. (2007) Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology, 68, 364-368. doi:10.1212/01.wnl.0000252813.86812.81
[40]	Mula, M., Trimble, M.R. and Sander, J.W.A.S. (2003) The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia, 44, 1573-1577. doi:10.1111/j.0013-9580.2003.19103.x
[41]	Mula, M., Trimble, M.R. and Sander, J.W. (2007) Psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam. Epilepsia, 48, 2322-2326.
[42]	Lambert, M.V. and Robertson, M.M. (1999) Depression in epilepsy: Etiology, phenomenology, and treatment. Epilepsia, 40, S21-S47. doi:10.1111/j.1528-1157.1999.tb00884.x
[43]	Shamim, S., Hasler, G., Liew, C.Z., Sato, S. and Theodore W.H. (2009) Temporal lobe epilepsy, depression, and hippocampal volume. Epilepsia, 50, 1067-1071. doi:10.1111/j.1528-1167.2008.01883.x
[44]	Ketter, T.A., Malow, B.A., Flamini, R., White, S.R., Post, R.M. and Theodore, W.H. (1994) Anticonvulsant withdrawal-emergent psychopathology. Neurology, 44, 55-61. doi:10.1212/WNL.44.1.55
[45]	Savard, G., Andermann, L.F., Reutens, D. and Andermann, F. (1998) Epilepsy, surgical treatment and postoperative psychiatric complications: A reevaluation of the evidence. In: Trimble, M.R. and Schmitz, B., Eds., Forced Normalization and Alternative Psychosis of Epilepsy Petersfield, Wrightson Biomedical, UK, 179-192.
[46]	Devinsky, O., Barr, W.B., Vickrey, B.G., et al. (2005) Changes in depression and anxiety after resective surgery for epilepsy. Neurology, 65, 1744-1749. doi:10.1212/01.wnl.0000187114.71524.c3
[47]	Blumer, D. and Altshuler, L.L. (1998) Affective disorders. In: Engelm J. and Pedley, T.A., Eds., Epilepsy: A Comprehensive Textbook, Lippincott-Raven, Philadelphia, 2083- 2099.
[48]	Kanner, A.M. and Palac, S. (2000) Depression in epilepsy: A common but often unrecognized comorbid malady. Epilepsy Behavior, 1, 37-51. doi:10.1006/ebeh.2000.0030
[49]	Gilliam, F. (2002) Optimizing health outcomes in active epilepsy. Neurology, 58, S9-S19. doi:10.1212/WNL.58.8_suppl_5.S9
[50]	Gilliam, F.G., Barry, J.J., Meador, K.J., et al. (2006) Rapid detection of major depression in epilepsy: A multicenter study. The Lancet Neurology, 5, 399-405. doi:10.1016/S1474-4422(06)70415-X
[51]	Robertson, M.M. and Trimble, M.R. (1985) The treatment of depression in patients with epilepsy. A doubleblind trial. Journal of Affective Disorders, 9, 127-136. doi:10.1016/0165-0327(85)90091-6
[52]	Kanner, A.M., Kozak, A.M. and Frey, M. (2000) The use of sertraline in patients with epilepsy: Is it safe? Epilepsy Behavior, 1, 100-105. doi:10.1006/ebeh.2000.0050
[53]	Pisani, F., Spina, E. and Oteri, G. (1999) Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice. Epilepsia. 40, S48-S56. doi:10.1111/j.1528-1157.1999.tb00885.x
[54]	Barry, J.J., Huynh, N. and Lembke, A. (2000) Depression in individuals with epilepsy. Current Treatment Options in Neurology, 2, 571-585. doi:10.1007/s11940-000-0035-9
[55]	Alper, K., Schwartz, K.A., Kolts, R.L. and Khan, A. (2007) Seizure incidence in psychopharmacological clinical trials: An analysis of food and drug administration (FDA) summary basis of approval reports. Biological Psychiatry, 62, 345-354. doi:10.1016/j.biopsych.2006.09.023
[56]	Krahn, L.E., Rummans, T.A., Peterson, G.C., et al. (1993) Electroconvulsive therapy for depression after temporal lobectomy for epilepsy. Convulsive Therapy, 9, 217-219.
[57]	Keller, M.B., McCullough, J.P., Klein, D.N., et al. (2000) A Comparison of nefazodone, the cognitive behavioral- analysis system of psychotherapy, and their combination for the treatment of chronic depression. The New England journal of medicine, 342, 1462-1470. doi:10.1056/NEJM200005183422001
[58]	Gilliam, F., Black, K.J., Carter, J., et al. (2009) Depression and health outcomes in epilepsy: A randomized trial. (Abstract presented at AAN 2009). Neurology, 72, A261- A262.
[59]	Rush, A.J., Marangell, L.B., Sackeim, H.A., et al. (2005) Vagus nerve stimulation for treatment-resistant depresssion: A randomized, controlled acute phase trial. Biological Psychiatry, 58, 347-549. doi:10.1016/j.biopsych.2005.05.025